Moreover, EPH/ephrin members can serve as prognostic biomarkers in the setting of different pediatric neoplasms, with their expression correlating both with dismal and favorable prognosis, depending on the EPH/ephrin and the tumor subtype. Here, EPHA1 is linked to neoplasm.